1Dermatological Institute of Jalisco, Zapopan, JAL, Mexico.
2Academic Department, School of Medicine, University of Monterrey, Monterrey, NL, Mexico.
*Corresponding Author : Gerardo Rivera Silva
Academic Department, School of Medicine, University of Monterrey, Monterrey, NL, Mexico.
Tel: +52-81-8215-1446;
Email: [email protected]
Received : Oct 07, 2023
Accepted : Nov 02, 2023
Published : Nov 09, 2023
Archived : www.jcimcr.org
Copyright : © Rivera-Silva G (2023).
Keywords: Serpiginous track; Pruritus; Ancylostoma braziliense; Ancylostoma caninum.
A 13-year-old female presented to our clinic with a pruritic, progressive, 5 centimeters long cutaneous linear erythema on the left foot. The patient informed us that the lesion appeared progressively 2 weeks before. She spent hours in contact with seawater and sand without protection due to beach holidays. At first, the patient detected irritated redness on the dorsum of her left foot. She noticed that the lesion progressed forming a tortuous red cutaneous line. No personal pathological history was reported. Physical examination revealed an erythematous linear serpiginous skin lesion on the dorsum of the left foot (Figure 1). The clinical diagnosis was cutaneous larva migrans caused by Ancylostoma braziliense. The patient was treated with cycles of 30 second with liquid nitrogen applied directly on the lesion, remitting completely.
Linear serpiginous lesion or larva migrans is a tropical parasitic condition caused by A. caninum or A. braziliensis, characterized by erythematous papule that appear between 24-48 hours; and within a few days they transform into a serpiginous, pruritic, and erythematous linear lesion [1,2]. Generally, this lesion is usually a single injury located on feet. In extraordinary cases the clinical presentation is visceral, such as Löffler syndrome. The diagnosis is clinical, and the treatment is variable, based in ivermectin, albendazole or cryotherapy. However, in some cases there could be a spontaneous remission between 2-8 weeks [2,3].
Conflict of interest: None of the other authors has any conflict of interest to declare concerning this paper.
Funding: None.